nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP2C19—Thalidomide—leprosy	0.0841	0.117	CbGbCtD
Doxepin—CYP2C19—Rifampicin—leprosy	0.0814	0.114	CbGbCtD
Doxepin—CYP1A2—Thalidomide—leprosy	0.0776	0.108	CbGbCtD
Doxepin—CYP1A2—Rifampicin—leprosy	0.0751	0.105	CbGbCtD
Doxepin—CYP2C9—Thalidomide—leprosy	0.0699	0.0976	CbGbCtD
Doxepin—CYP2C9—Rifampicin—leprosy	0.0677	0.0945	CbGbCtD
Doxepin—CYP2C19—Dapsone—leprosy	0.0672	0.0938	CbGbCtD
Doxepin—ABCB1—Rifampicin—leprosy	0.0657	0.0917	CbGbCtD
Doxepin—CYP2C9—Dapsone—leprosy	0.0559	0.078	CbGbCtD
Doxepin—CYP3A4—Rifampicin—leprosy	0.0394	0.0549	CbGbCtD
Doxepin—CYP3A4—Dapsone—leprosy	0.0325	0.0454	CbGbCtD
Doxepin—Joint sprain—Dapsone—leprosy	0.0162	0.0742	CcSEcCtD
Doxepin—Ligament sprain—Dapsone—leprosy	0.0129	0.0589	CcSEcCtD
Doxepin—Parotid gland enlargement—Thalidomide—leprosy	0.00796	0.0364	CcSEcCtD
Doxepin—Application site reaction—Dapsone—leprosy	0.00695	0.0317	CcSEcCtD
Doxepin—HRH1—nose—leprosy	0.0059	0.0911	CbGeAlD
Doxepin—Enuresis—Thalidomide—leprosy	0.00584	0.0267	CcSEcCtD
Doxepin—Suicide attempt—Dapsone—leprosy	0.00574	0.0262	CcSEcCtD
Doxepin—CHRM5—skin epidermis—leprosy	0.00499	0.0771	CbGeAlD
Doxepin—Rales—Thalidomide—leprosy	0.00407	0.0186	CcSEcCtD
Doxepin—HTR2A—trigeminal nerve—leprosy	0.00387	0.0597	CbGeAlD
Doxepin—Aphthous stomatitis—Thalidomide—leprosy	0.00356	0.0162	CcSEcCtD
Doxepin—Suicide attempt—Thalidomide—leprosy	0.00294	0.0134	CcSEcCtD
Doxepin—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00287	0.0131	CcSEcCtD
Doxepin—HTR2A—cranial nerve—leprosy	0.00275	0.0425	CbGeAlD
Doxepin—Galactorrhoea—Thalidomide—leprosy	0.00257	0.0117	CcSEcCtD
Doxepin—SLC6A2—nerve—leprosy	0.00235	0.0363	CbGeAlD
Doxepin—HTR2A—hindlimb—leprosy	0.00232	0.0358	CbGeAlD
Doxepin—Psychotic disorder—Dapsone—leprosy	0.00231	0.0106	CcSEcCtD
Doxepin—DRD2—nerve—leprosy	0.00214	0.033	CbGeAlD
Doxepin—ADRA2A—peripheral nervous system—leprosy	0.00213	0.0329	CbGeAlD
Doxepin—Nasopharyngitis—Dapsone—leprosy	0.00212	0.00966	CcSEcCtD
Doxepin—Tingling sensation—Thalidomide—leprosy	0.00208	0.00948	CcSEcCtD
Doxepin—Influenza—Dapsone—leprosy	0.00204	0.00934	CcSEcCtD
Doxepin—Petechiae—Thalidomide—leprosy	0.00203	0.00926	CcSEcCtD
Doxepin—Numbness—Thalidomide—leprosy	0.00201	0.00919	CcSEcCtD
Doxepin—HTR2A—appendage—leprosy	0.00199	0.0307	CbGeAlD
Doxepin—Apnoea—Thalidomide—leprosy	0.00197	0.00899	CcSEcCtD
Doxepin—Sensory loss—Thalidomide—leprosy	0.00193	0.00879	CcSEcCtD
Doxepin—Jaundice cholestatic—Thalidomide—leprosy	0.0019	0.00867	CcSEcCtD
Doxepin—Viral infection—Thalidomide—leprosy	0.00185	0.00843	CcSEcCtD
Doxepin—Hyperbilirubinaemia—Thalidomide—leprosy	0.00183	0.00838	CcSEcCtD
Doxepin—Thinking abnormal—Thalidomide—leprosy	0.00182	0.00832	CcSEcCtD
Doxepin—HTR2A—peripheral nervous system—leprosy	0.00181	0.028	CbGeAlD
Doxepin—Neuropathy peripheral—Dapsone—leprosy	0.00179	0.00816	CcSEcCtD
Doxepin—CHRM5—eye—leprosy	0.00178	0.0274	CbGeAlD
Doxepin—Dyskinesia—Thalidomide—leprosy	0.00178	0.00811	CcSEcCtD
Doxepin—Hearing impaired—Thalidomide—leprosy	0.00175	0.008	CcSEcCtD
Doxepin—Atrioventricular block—Thalidomide—leprosy	0.00172	0.00785	CcSEcCtD
Doxepin—Sinusitis—Dapsone—leprosy	0.00171	0.00781	CcSEcCtD
Doxepin—Gait disturbance—Thalidomide—leprosy	0.00171	0.00781	CcSEcCtD
Doxepin—Neck pain—Thalidomide—leprosy	0.00169	0.00771	CcSEcCtD
Doxepin—Hyperkalaemia—Thalidomide—leprosy	0.00164	0.00749	CcSEcCtD
Doxepin—Pharyngitis—Dapsone—leprosy	0.00162	0.00742	CcSEcCtD
Doxepin—HRH2—skin of body—leprosy	0.00162	0.025	CbGeAlD
Doxepin—CHRM5—skin of body—leprosy	0.00155	0.0239	CbGeAlD
Doxepin—Tinnitus—Dapsone—leprosy	0.00153	0.00697	CcSEcCtD
Doxepin—Gynaecomastia—Thalidomide—leprosy	0.00149	0.00682	CcSEcCtD
Doxepin—Mental disability—Thalidomide—leprosy	0.00145	0.00661	CcSEcCtD
Doxepin—Erythema—Dapsone—leprosy	0.00142	0.00651	CcSEcCtD
Doxepin—HTR2A—nerve—leprosy	0.00141	0.0218	CbGeAlD
Doxepin—Gastroenteritis—Thalidomide—leprosy	0.00137	0.00624	CcSEcCtD
Doxepin—Vascular purpura—Thalidomide—leprosy	0.00135	0.00618	CcSEcCtD
Doxepin—Deafness—Thalidomide—leprosy	0.00135	0.00618	CcSEcCtD
Doxepin—Eczema—Thalidomide—leprosy	0.00135	0.00615	CcSEcCtD
Doxepin—Vision blurred—Dapsone—leprosy	0.00134	0.00613	CcSEcCtD
Doxepin—Eye pain—Thalidomide—leprosy	0.00134	0.00613	CcSEcCtD
Doxepin—Libido decreased—Thalidomide—leprosy	0.00131	0.00596	CcSEcCtD
Doxepin—Increased appetite—Thalidomide—leprosy	0.00129	0.00589	CcSEcCtD
Doxepin—Vertigo—Dapsone—leprosy	0.00128	0.00585	CcSEcCtD
Doxepin—Purpura—Thalidomide—leprosy	0.00126	0.00574	CcSEcCtD
Doxepin—CHRM4—testis—leprosy	0.00125	0.0193	CbGeAlD
Doxepin—Cough—Dapsone—leprosy	0.00124	0.00568	CcSEcCtD
Doxepin—Cerebrovascular accident—Thalidomide—leprosy	0.00124	0.00564	CcSEcCtD
Doxepin—Lethargy—Thalidomide—leprosy	0.00124	0.00564	CcSEcCtD
Doxepin—CHRM4—nervous system—leprosy	0.00122	0.0189	CbGeAlD
Doxepin—Diplopia—Thalidomide—leprosy	0.00121	0.00553	CcSEcCtD
Doxepin—Pain in extremity—Thalidomide—leprosy	0.00121	0.00553	CcSEcCtD
Doxepin—Disturbance in sexual arousal—Thalidomide—leprosy	0.0012	0.00549	CcSEcCtD
Doxepin—Migraine—Thalidomide—leprosy	0.00119	0.00544	CcSEcCtD
Doxepin—Psychotic disorder—Thalidomide—leprosy	0.00118	0.0054	CcSEcCtD
Doxepin—Ataxia—Thalidomide—leprosy	0.00114	0.0052	CcSEcCtD
Doxepin—Tachycardia—Dapsone—leprosy	0.00113	0.00518	CcSEcCtD
Doxepin—HTR2A—blood vessel—leprosy	0.00111	0.0171	CbGeAlD
Doxepin—Hypokalaemia—Thalidomide—leprosy	0.0011	0.00503	CcSEcCtD
Doxepin—HTR6—nervous system—leprosy	0.0011	0.0169	CbGeAlD
Doxepin—Breast disorder—Thalidomide—leprosy	0.00109	0.005	CcSEcCtD
Doxepin—Cramp muscle—Thalidomide—leprosy	0.00109	0.00498	CcSEcCtD
Doxepin—Alanine aminotransferase increased—Thalidomide—leprosy	0.00107	0.00488	CcSEcCtD
Doxepin—Insomnia—Dapsone—leprosy	0.00105	0.0048	CcSEcCtD
Doxepin—Influenza—Thalidomide—leprosy	0.00105	0.00478	CcSEcCtD
Doxepin—Eosinophilia—Thalidomide—leprosy	0.00104	0.00473	CcSEcCtD
Doxepin—Bronchitis—Thalidomide—leprosy	0.00101	0.0046	CcSEcCtD
Doxepin—HRH2—nervous system—leprosy	0.001	0.0155	CbGeAlD
Doxepin—Pancytopenia—Thalidomide—leprosy	0.000994	0.00454	CcSEcCtD
Doxepin—Upper respiratory tract infection—Thalidomide—leprosy	0.000973	0.00444	CcSEcCtD
Doxepin—Pollakiuria—Thalidomide—leprosy	0.000967	0.00442	CcSEcCtD
Doxepin—Erectile dysfunction—Thalidomide—leprosy	0.000964	0.0044	CcSEcCtD
Doxepin—HTR2B—skin of body—leprosy	0.000961	0.0148	CbGeAlD
Doxepin—CHRM5—nervous system—leprosy	0.000957	0.0148	CbGeAlD
Doxepin—Weight increased—Thalidomide—leprosy	0.000952	0.00435	CcSEcCtD
Doxepin—Gastrointestinal pain—Dapsone—leprosy	0.000951	0.00434	CcSEcCtD
Doxepin—Pneumonia—Thalidomide—leprosy	0.000939	0.00429	CcSEcCtD
Doxepin—Infestation NOS—Thalidomide—leprosy	0.000933	0.00426	CcSEcCtD
Doxepin—Drowsiness—Thalidomide—leprosy	0.000933	0.00426	CcSEcCtD
Doxepin—Infestation—Thalidomide—leprosy	0.000933	0.00426	CcSEcCtD
Doxepin—Abdominal pain—Dapsone—leprosy	0.000919	0.0042	CcSEcCtD
Doxepin—Body temperature increased—Dapsone—leprosy	0.000919	0.0042	CcSEcCtD
Doxepin—Neuropathy peripheral—Thalidomide—leprosy	0.000915	0.00418	CcSEcCtD
Doxepin—Stomatitis—Thalidomide—leprosy	0.00091	0.00415	CcSEcCtD
Doxepin—Sweating—Thalidomide—leprosy	0.000895	0.00409	CcSEcCtD
Doxepin—DRD2—eye—leprosy	0.000894	0.0138	CbGeAlD
Doxepin—Sinusitis—Thalidomide—leprosy	0.000875	0.004	CcSEcCtD
Doxepin—ADRA1B—nervous system—leprosy	0.000874	0.0135	CbGeAlD
Doxepin—Agranulocytosis—Thalidomide—leprosy	0.000871	0.00398	CcSEcCtD
Doxepin—ADRA1D—nervous system—leprosy	0.000855	0.0132	CbGeAlD
Doxepin—Bradycardia—Thalidomide—leprosy	0.000853	0.00389	CcSEcCtD
Doxepin—Hepatitis—Thalidomide—leprosy	0.000838	0.00383	CcSEcCtD
Doxepin—Hypoaesthesia—Thalidomide—leprosy	0.000834	0.00381	CcSEcCtD
Doxepin—Pharyngitis—Thalidomide—leprosy	0.000831	0.0038	CcSEcCtD
Doxepin—Urinary tract disorder—Thalidomide—leprosy	0.000827	0.00378	CcSEcCtD
Doxepin—Oedema peripheral—Thalidomide—leprosy	0.000825	0.00377	CcSEcCtD
Doxepin—Urethral disorder—Thalidomide—leprosy	0.000821	0.00375	CcSEcCtD
Doxepin—Eye disorder—Thalidomide—leprosy	0.000783	0.00358	CcSEcCtD
Doxepin—Tinnitus—Thalidomide—leprosy	0.000781	0.00357	CcSEcCtD
Doxepin—Cardiac disorder—Thalidomide—leprosy	0.000777	0.00355	CcSEcCtD
Doxepin—Angiopathy—Thalidomide—leprosy	0.00076	0.00347	CcSEcCtD
Doxepin—Immune system disorder—Thalidomide—leprosy	0.000757	0.00346	CcSEcCtD
Doxepin—Mediastinal disorder—Thalidomide—leprosy	0.000755	0.00345	CcSEcCtD
Doxepin—Chills—Thalidomide—leprosy	0.000752	0.00343	CcSEcCtD
Doxepin—Arrhythmia—Thalidomide—leprosy	0.000748	0.00342	CcSEcCtD
Doxepin—Alopecia—Thalidomide—leprosy	0.00074	0.00338	CcSEcCtD
Doxepin—Vomiting—Dapsone—leprosy	0.000739	0.00338	CcSEcCtD
Doxepin—Mental disorder—Thalidomide—leprosy	0.000734	0.00335	CcSEcCtD
Doxepin—HTR2B—tendon—leprosy	0.000732	0.0113	CbGeAlD
Doxepin—Malnutrition—Thalidomide—leprosy	0.000729	0.00333	CcSEcCtD
Doxepin—Headache—Dapsone—leprosy	0.000728	0.00333	CcSEcCtD
Doxepin—ABCB1—blood vessel—leprosy	0.000726	0.0112	CbGeAlD
Doxepin—Flatulence—Thalidomide—leprosy	0.000719	0.00328	CcSEcCtD
Doxepin—Tension—Thalidomide—leprosy	0.000716	0.00327	CcSEcCtD
Doxepin—Dysgeusia—Thalidomide—leprosy	0.000714	0.00326	CcSEcCtD
Doxepin—Nervousness—Thalidomide—leprosy	0.000708	0.00323	CcSEcCtD
Doxepin—HRH1—eye—leprosy	0.000706	0.0109	CbGeAlD
Doxepin—Back pain—Thalidomide—leprosy	0.000705	0.00322	CcSEcCtD
Doxepin—ORM1—nervous system—leprosy	0.000704	0.0109	CbGeAlD
Doxepin—Muscle spasms—Thalidomide—leprosy	0.000701	0.0032	CcSEcCtD
Doxepin—Nausea—Dapsone—leprosy	0.000691	0.00315	CcSEcCtD
Doxepin—Vision blurred—Thalidomide—leprosy	0.000687	0.00314	CcSEcCtD
Doxepin—Tremor—Thalidomide—leprosy	0.000683	0.00312	CcSEcCtD
Doxepin—Ill-defined disorder—Thalidomide—leprosy	0.000677	0.00309	CcSEcCtD
Doxepin—Anaemia—Thalidomide—leprosy	0.000674	0.00308	CcSEcCtD
Doxepin—Agitation—Thalidomide—leprosy	0.00067	0.00306	CcSEcCtD
Doxepin—Malaise—Thalidomide—leprosy	0.000658	0.003	CcSEcCtD
Doxepin—CHRM2—nervous system—leprosy	0.000657	0.0101	CbGeAlD
Doxepin—Vertigo—Thalidomide—leprosy	0.000655	0.00299	CcSEcCtD
Doxepin—Syncope—Thalidomide—leprosy	0.000654	0.00299	CcSEcCtD
Doxepin—Leukopenia—Thalidomide—leprosy	0.000653	0.00298	CcSEcCtD
Doxepin—Palpitations—Thalidomide—leprosy	0.000644	0.00294	CcSEcCtD
Doxepin—Loss of consciousness—Thalidomide—leprosy	0.000641	0.00293	CcSEcCtD
Doxepin—Cough—Thalidomide—leprosy	0.000636	0.00291	CcSEcCtD
Doxepin—HTR2C—nervous system—leprosy	0.000633	0.00977	CbGeAlD
Doxepin—Convulsion—Thalidomide—leprosy	0.000632	0.00289	CcSEcCtD
Doxepin—Hypertension—Thalidomide—leprosy	0.00063	0.00288	CcSEcCtD
Doxepin—Chest pain—Thalidomide—leprosy	0.000621	0.00284	CcSEcCtD
Doxepin—Myalgia—Thalidomide—leprosy	0.000621	0.00284	CcSEcCtD
Doxepin—Arthralgia—Thalidomide—leprosy	0.000621	0.00284	CcSEcCtD
Doxepin—Anxiety—Thalidomide—leprosy	0.000619	0.00283	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000617	0.00282	CcSEcCtD
Doxepin—Discomfort—Thalidomide—leprosy	0.000613	0.0028	CcSEcCtD
Doxepin—Dry mouth—Thalidomide—leprosy	0.000607	0.00277	CcSEcCtD
Doxepin—Confusional state—Thalidomide—leprosy	0.0006	0.00274	CcSEcCtD
Doxepin—SLC6A4—nervous system—leprosy	0.0006	0.00926	CbGeAlD
Doxepin—CHRM1—nervous system—leprosy	0.000598	0.00923	CbGeAlD
Doxepin—Oedema—Thalidomide—leprosy	0.000595	0.00272	CcSEcCtD
Doxepin—HTR2B—nervous system—leprosy	0.000594	0.00918	CbGeAlD
Doxepin—Infection—Thalidomide—leprosy	0.000591	0.0027	CcSEcCtD
Doxepin—HTR2A—eye—leprosy	0.00059	0.00911	CbGeAlD
Doxepin—Shock—Thalidomide—leprosy	0.000586	0.00267	CcSEcCtD
Doxepin—Nervous system disorder—Thalidomide—leprosy	0.000584	0.00267	CcSEcCtD
Doxepin—Thrombocytopenia—Thalidomide—leprosy	0.000583	0.00266	CcSEcCtD
Doxepin—Tachycardia—Thalidomide—leprosy	0.000581	0.00265	CcSEcCtD
Doxepin—Skin disorder—Thalidomide—leprosy	0.000578	0.00264	CcSEcCtD
Doxepin—ADRA2C—tendon—leprosy	0.000576	0.00889	CbGeAlD
Doxepin—Hyperhidrosis—Thalidomide—leprosy	0.000575	0.00263	CcSEcCtD
Doxepin—Anorexia—Thalidomide—leprosy	0.000567	0.00259	CcSEcCtD
Doxepin—Hypotension—Thalidomide—leprosy	0.000556	0.00254	CcSEcCtD
Doxepin—CHRM3—testis—leprosy	0.000545	0.00842	CbGeAlD
Doxepin—Musculoskeletal discomfort—Thalidomide—leprosy	0.000542	0.00248	CcSEcCtD
Doxepin—Insomnia—Thalidomide—leprosy	0.000538	0.00246	CcSEcCtD
Doxepin—SLC6A2—testis—leprosy	0.000538	0.00831	CbGeAlD
Doxepin—CHRM3—nervous system—leprosy	0.000535	0.00826	CbGeAlD
Doxepin—Paraesthesia—Thalidomide—leprosy	0.000534	0.00244	CcSEcCtD
Doxepin—HTR1A—nervous system—leprosy	0.000533	0.00823	CbGeAlD
Doxepin—Dyspnoea—Thalidomide—leprosy	0.000531	0.00242	CcSEcCtD
Doxepin—Somnolence—Thalidomide—leprosy	0.000529	0.00242	CcSEcCtD
Doxepin—SLC6A2—nervous system—leprosy	0.000528	0.00816	CbGeAlD
Doxepin—Dyspepsia—Thalidomide—leprosy	0.000524	0.00239	CcSEcCtD
Doxepin—Decreased appetite—Thalidomide—leprosy	0.000517	0.00236	CcSEcCtD
Doxepin—Gastrointestinal disorder—Thalidomide—leprosy	0.000514	0.00235	CcSEcCtD
Doxepin—Fatigue—Thalidomide—leprosy	0.000513	0.00234	CcSEcCtD
Doxepin—Constipation—Thalidomide—leprosy	0.000509	0.00232	CcSEcCtD
Doxepin—Pain—Thalidomide—leprosy	0.000509	0.00232	CcSEcCtD
Doxepin—ADRA1A—nervous system—leprosy	0.000491	0.00758	CbGeAlD
Doxepin—Feeling abnormal—Thalidomide—leprosy	0.00049	0.00224	CcSEcCtD
Doxepin—DRD2—testis—leprosy	0.00049	0.00757	CbGeAlD
Doxepin—Gastrointestinal pain—Thalidomide—leprosy	0.000487	0.00222	CcSEcCtD
Doxepin—KCNH2—testis—leprosy	0.000483	0.00746	CbGeAlD
Doxepin—DRD2—nervous system—leprosy	0.000481	0.00743	CbGeAlD
Doxepin—ADRA2C—testis—leprosy	0.000477	0.00736	CbGeAlD
Doxepin—KCNH2—nervous system—leprosy	0.000474	0.00732	CbGeAlD
Doxepin—Urticaria—Thalidomide—leprosy	0.000473	0.00216	CcSEcCtD
Doxepin—Body temperature increased—Thalidomide—leprosy	0.00047	0.00215	CcSEcCtD
Doxepin—Abdominal pain—Thalidomide—leprosy	0.00047	0.00215	CcSEcCtD
Doxepin—ADRA2C—nervous system—leprosy	0.000468	0.00723	CbGeAlD
Doxepin—HRH1—tendon—leprosy	0.000468	0.00722	CbGeAlD
Doxepin—ADRA2A—tendon—leprosy	0.000459	0.00709	CbGeAlD
Doxepin—Hypersensitivity—Thalidomide—leprosy	0.000438	0.002	CcSEcCtD
Doxepin—Asthenia—Thalidomide—leprosy	0.000427	0.00195	CcSEcCtD
Doxepin—Pruritus—Thalidomide—leprosy	0.000421	0.00192	CcSEcCtD
Doxepin—Diarrhoea—Thalidomide—leprosy	0.000407	0.00186	CcSEcCtD
Doxepin—Dizziness—Thalidomide—leprosy	0.000394	0.0018	CcSEcCtD
Doxepin—HTR2A—tendon—leprosy	0.000391	0.00603	CbGeAlD
Doxepin—HRH1—testis—leprosy	0.000387	0.00598	CbGeAlD
Doxepin—ADRA2A—testis—leprosy	0.00038	0.00587	CbGeAlD
Doxepin—HRH1—nervous system—leprosy	0.00038	0.00587	CbGeAlD
Doxepin—Vomiting—Thalidomide—leprosy	0.000378	0.00173	CcSEcCtD
Doxepin—Rash—Thalidomide—leprosy	0.000375	0.00171	CcSEcCtD
Doxepin—Dermatitis—Thalidomide—leprosy	0.000375	0.00171	CcSEcCtD
Doxepin—ADRA2A—nervous system—leprosy	0.000373	0.00577	CbGeAlD
Doxepin—Headache—Thalidomide—leprosy	0.000373	0.0017	CcSEcCtD
Doxepin—Nausea—Thalidomide—leprosy	0.000354	0.00161	CcSEcCtD
Doxepin—HTR2A—testis—leprosy	0.000323	0.005	CbGeAlD
Doxepin—HTR2A—nervous system—leprosy	0.000317	0.0049	CbGeAlD
Doxepin—CYP2D6—testis—leprosy	0.000295	0.00455	CbGeAlD
Doxepin—CYP3A4—nervous system—leprosy	0.000294	0.00454	CbGeAlD
Doxepin—CYP2D6—nervous system—leprosy	0.000289	0.00447	CbGeAlD
Doxepin—ABCB1—testis—leprosy	0.000212	0.00327	CbGeAlD
Doxepin—ABCB1—nervous system—leprosy	0.000208	0.00321	CbGeAlD
